Hepatitis C virus infection of human T lymphocytes is mediated by CD5

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3723-3735

  Sarhan, Mohammed A ^a   Pham, Tram N Q ^a   Chen, Annie Y ^a   Michalak, Tomasz I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CD81 ANTIGEN; PROTEIN ANTIBODY; SHORT HAIRPIN RNA; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFECTION SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS REPLICATION;

ANTIGENS, CD5; CELL LINE; HEPACIVIRUS; HEPATITIS C; HUMANS; T-LYMPHOCYTES;

HEPATITIS C VIRUS;

EID: 84861321809     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06956-11     Document Type: Article

References (42)

1. Bartosch B, et al. 2003. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278: 41624-41630.
2. Benedicto I, et al. 2009. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J. Virol. 83: 8012-8020.
3. Blackard JT, Kemmer N, Sherman KE. 2006. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44: 15-22.
4. Chuang SS, et al. 2010. Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas. J. Clin. Pathol. 63: 595-598.
5. Ciurea A, et al. 1999. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. Proc. Natl. Acad. Sci. U. S. A. 96: 11964-11969.
6. Di Liberto G, et al. 2006. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 131: 76-84.
7. Ducoulombier D, et al. 2004. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39: 817-825.
8. Durand T, et al. 2010. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes. Gut 59: 934-942.
9. Evans MJ, et al. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
10. Ferri C, et al. 1993. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82: 3701-3704.
11. Foley GE, et al. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522-529.
12. Germi R, et al. 2002. Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J. Med. Virol. 68: 206-215.
13. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. 2003. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125: 1723-1732.
14. Griffin DE. 2010. Measles virus-induced suppression of immune responses. Immunol. Rev. 236: 176-189.
15. Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV. 2007. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81: 374-383.
16. Laskus T, et al. 2000. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J. Infect. Dis. 181: 442-448.
17. Lerat H, et al. 1996. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J. Clin. Invest. 97: 845-851.
18. Lin K, Perni RB, Kwong AD, Lin C. 2006. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells. Antimicrob. Agents Chemother. 50: 1813-1822.
19. Liu S, et al. 2009. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83: 2011-2014.
20. Lozano F, Alberola-Ila J, Places L, Gallart T, Vives J. 1990. Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells. Immunology 70: 434-439.
21. Lusso P, et al. 1995. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-linetropic HIV-1. J. Virol. 69: 3712-3720.
22. MacParland SA, Pham TNQ, Gujar SA, Michalak TI. 2006. De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro. J. Gen. Virol. 87: 3577-3586.
23. MacParland SA, Pham TNQ, Guy CS, Michalak TI. 2009. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 49: 1431-1441.
24. McCaughan GW, Shackel NA, Bertolino P, Bowen DG. 2009. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes. Transplantation 87: 1105-1111.
25. Melon S, et al. 2005. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transplant. Proc. 37: 2083-2085.
26. Michalak TI. 2000. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol. Rev. 174: 98-111.
27. Michalak TI, Hodgson PD, Churchill ND. 2000. Postranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J. Virol. 74: 4483-4494.
28. Navas S, Martin J, Quiroga JA, Castillo I, Carreno V. 1998. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J. Virol. 72: 1640-1646.
29. Oldstone MB. 1996. Virus-lymphoid cell interactions. Proc. Natl. Acad. Sci. U. S. A. 93: 12756-12758.
30. Pal S, et al. 2006. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 130: 1107-1116.
31. Pham TN, et al. 2008. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 134: 812-822.
32. Pham TNQ, et al. 2005. Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J. Gen. Virol. 86: 657-666.
33. Pham TNQ, et al. 2004. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 78: 5867-5874.
34. Pham TNQ, Mercer SE, Michalak TI. 2009. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J. Viral Hepat. 16: 547-556.
35. Ploss A, et al. 2009. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457: 882-886.
36. Russell RS, et al. 2008. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 105: 4370-4375.
37. Sarrias MR, et al. 2004. The scavenger receptor cysteine-rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit. Rev. Immunol. 24: 1-37.
38. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. 1992. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Natl. Acad. Sci. U. S. A. 89: 5477-5481.
39. Thomas RM, et al. 2003. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl. 9: 905-915.
40. Tkoub ME, Haioun C, Pawlotsky JM, Dhumeaux D, Delchier JC. 1998. Chronic hepatitis C virus and gastric MALT lymphoma. Blood 91: 360.
41. Wakita T, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11: 791-796.
42. Zignego AL, Giannini C, Monti M, Gragnani L. 2007. Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig. Liver Dis. Vasanth9 39(Suppl. 1): S38-S45.